Table 1. Comparison of clinical and pathologic characteristics by tumor SHBG intensity.
SHBG IHC score | |||||
1 (weak) | 2 (moderate) | 3 (strong) | p value | ||
N | Total N | 65 | 93 | 90 | |
Age (years old): | 0.200 | ||||
≤49 | 57 | 19 | 19 | 19 | |
(33.3%) | (33.3%) | (33.3%) | |||
≥50 | 175 | 41 | 66 | 68 | |
(23.4%) | (37.7%) | (38.9%) | |||
Missing | 16 | ||||
Histological subtype: | 0.022 | ||||
Serous | 163 | 41 | 55 | 67 | |
(25.2%) | (33.7%) | (41.1%) | |||
Muci+Endo | 37 | 17 | 13 | 7 | |
(45.0%) | (35.1%) | (18.9%) | |||
Clea+Mixe+Undi | 27 | 4 | 12 | 11 | |
(14.8%) | (44.4%) | (40.7%) | |||
Others or unclassified | 21 | ||||
FIGO Stage: | 0.018 | ||||
I+II | 46 | 16 | 19 | 11 | |
(34.8%) | (41.3%) | (23.9%) | |||
III | 117 | 32 | 42 | 43 | |
(27.4%) | (35.9%) | (36.8%) | |||
IV | 79 | 17 | 26 | 36 | |
(21.5%) | (32.9%) | (45.6%) | |||
Not staged or missing | 6 | ||||
Histological Grade: | 0.020 | ||||
Well | 19 | 6 | 10 | 3 | |
(31.6%) | (52.6%) | (15.8%) | |||
Moderate | 62 | 18 | 26 | 18 | |
(29.0%) | (41.9%) | (29.0%) | |||
Poor | 133 | 31 | 43 | 59 | |
(23.3%) | (32.3%) | (44.4%) | |||
Not graded or missing | 34 |
Muci, Mucinous tumor; Endo, Endometrioid; Clea, Clear cell; Mixe, Mixed epithelial tumor; Undi, Undifferenciated tumor.